Goal: The conference will be segmented to emphasize the role of the microbiota in human health and disease. Topics to be covered will include the role of the microbiota in IBD, IBS, obesity, celiac disease and in fatty liver disease.

​

Target Audience: The 2024 Gut Microbiome Conference will bring together gastroenterologists, nurse practitioners, nurses, physician assistants, and other health care professionals with direct research and/or treatment interest in this field.

​

Learning Objectives:

Upon completion of this activity, participants should be able to:

• Discuss evolving concepts regarding the role of the gut microbiome in gastrointestinal health and disease

• Describe current research advances in understanding the composition and function of the gut microbiome

• Discuss how modification of the gut microbiome can be used as a therapeutic strategy in gastrointestinal diseases

​

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Gi Health Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

​

The University of Cincinnati designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​

Disclosure Statement:

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

​

All additional planning committee members, the University of Cincinnati staff and the Gi Health Foundation staff have no relationships to disclose.

​

Learner Assurance Statement:

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

​

Disclaimer Statement:

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

​

Jointly provided by the University of Cincinnati and the Gi Health Foundation.

​

​

​

​

​

​

 

Supported by educational grants from Salix Pharmaceuticals and Ferring Pharmaceuticals, Inc.

​

​